Literature DB >> 23375760

Outcomes after transjugular intrahepatic portosystemic stent shunt: a "bridge" to nowhere.

Paul G Toomey1, Sharona B Ross, Farhaad C Golkar, Jonathan M Hernandez, Whalen C Clark, Kenneth Luberice, Angel E Alsina, Alexander S Rosemurgy.   

Abstract

BACKGROUND: Transjugular intrahepatic portosystemic stent shunt (TIPS) has become the modality of choice for complicated portal decompression. This study was undertaken to determine outcomes after TIPS and the usefulness of TIPS as a "bridge" to transplantation.
METHODS: Patients undergoing TIPS from 2001 to 2010 at a teaching hospital with a transplant program were studied. The median data are presented.
RESULTS: TIPS was undertaken in 256 patients. TIPS decreased portal vein-inferior vena cava (IVC) gradients from 17 to 5 mm Hg (P < .001). Reinterventions were undertaken in 54 patients (21%). Survival after TIPS was 26 months; liver transplantation was undertaken in 35 (14%) patients.
CONCLUSIONS: TIPS effectively decompresses portal hypertension but leads to frequent reinterventions and short survival. After TIPS, liver transplantation is uncommonly undertaken. TIPS is a "bridge" to transplantation that is seldom "crossed," and TIPS continues to be plagued by frequent reinterventions. Outcomes after TIPS and the infrequency of transplantation after TIPS make it difficult to recommend on merit.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375760     DOI: 10.1016/j.amjsurg.2012.06.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Transjugular intrahepatic portosystemic shunt creation may be associated with hyperplastic hepatic nodular lesions in the long term: an analysis of 18 pediatric and young adult patients.

Authors:  Andrew J Woerner; David S Shin; Jeffrey Forris Beecham Chick; Kevin S H Koo; Evelyn K Hsu; Elizabeth R Tang; Eric J Monroe
Journal:  Pediatr Radiol       Date:  2021-03-30

2.  Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.

Authors:  Chikwendu J Ede; Dimitrinka Nikolova; Martin Brand
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

3.  Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data.

Authors:  Hyung Ki Kim; Yoon Jun Kim; Woo Jin Chung; Soon Sun Kim; Jae Jun Shim; Moon Seok Choi; Do Young Kim; Dae Won Jun; Soon Ho Um; Sung Jae Park; Hyun Young Woo; Young Kul Jung; Soon Koo Baik; Moon Young Kim; Soo Young Park; Jae Myeong Lee; Young Seok Kim
Journal:  Clin Mol Hepatol       Date:  2014-03-26

4.  Renal-function change after transjugular intra-hepatic portosystemic shunt placement and its relationship with survival: a single-center experience.

Authors:  Min Lang; Angela L Lang; Brian Q Tsui; Weiping Wang; Brian K Erly; Bo Shen; Baljendra Kapoor
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-12-03

5.  Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.

Authors:  Martin Brand; Leanne Prodehl; Chikwendu J Ede
Journal:  Cochrane Database Syst Rev       Date:  2018-10-31

6.  Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization.

Authors:  Takayuki Kogure; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Tooru Shimosegawa
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.